Scientific posters

An overview of the conference posters:

  • C. Talbot, A. Appanvel, A. Botma, T. Rancati, A. Webb, D. Azria, T. Burr, J. Chang-Claude, C. Herskind, D. De Ruysscher, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, B. Rosenstein, T. Rattay, A. Vega, F. Wenz, R. Valdagni, C. West: Radiation Induced Lymphocyte Apoptosis assay as a predictor for radiotherapy side effects.  ESTRO 36, Vienna, Austria, May 5-9, 2017. Abstract


  • D. De Ruysscher, G. Defraene, B. Ramaekers, P. Lambin, E. Briers, H. Stobart, T. Ward, S. Bentzen, T. Van Staa, S. Kerns, C. West: Optimal design and patient selection for interventional trials using radiogenomics biomarkers. ESTRO 36, Vienna, Austria, May 5-9, 2017. Abstract


  • Tim Rattay, Kerstie Johnson, R Paul Symonds, Petra Seibold, Jenny Chang-Claude, Gillian Barnett, Charlotte Coles, David Azria, Frederik Wenz, Catharine West, Christopher Talbot, on behalf of the REQUITE study group: Development and validation of a predictive risk model for acute skin toxicity in patients undergoing breast radiotherapy. 15th St. Gallen International Breast Cancer Conference, Vienna, Austria, March 15-18, 2017. Poster


  • Rattay T, Johnson K, Azria D, Chang-Claude J, Davidson S, Dunning A, de Ruyscher D, Guiterrez-Enriquez S, Lambin P, Rancati T, Rosenstein B, Seibold P, Symonds RP, Thierens H, Valdagni R, Vega A, Webb A, Wenz F, West C, Talbot C: The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients. 2016 San Antonio Breast Cancer Symposium, San Antonio, Texas, United Stares of America, December 6-10, 2016 Abstract